Director's Dealing • Jun 10, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
| FORM 44 | OMB APPROVAL | |||||
|---|---|---|---|---|---|---|
| Check this box if no longer subject to Section 1166 Form 44 or Form 55 obligations may continue See Instruction 11((b)) Check this box to indicate that a transaction was made pursuant to a contract,, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 1100b55--11((c)) See Instruction 1100 ((Print or Type Responses)) |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,, DC 2200554499 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 1166((a)) of the Securities Exchange Act of 11993344 or Section 3300((h)) of the Investment Company Act of 11994400 |
OMB Number:: 33223355--00228877 Estimated average burden hours per response 0055 |
||||
| 11 Name and Address of Reporting Person ** Lieberman Gerald M |
22 Issuer Name and Ticker or Trading Symbol Teva Pharmaceutical Industries Limited [ TEVA ] |
55 Relationship of Reporting Person((s)) to Issuer | ((Check all applicable)) _____ 1100%% Owner |
|||
| ((Last)) ((First)) C//O Teva Pharmaceutical Industries Ltd 112244 Dvora HaNevi''a St,, |
((Middle)) | 33 Date of Earliest Transaction ((Month//Day//Year)) 0066//0055//22002255 |
__ X __ Director _____ Officer ((give title below)) |
_____ Other ((specify below)) | ||
| ((Street)) | 44 If Amendment,, Date Original Filed ((Month//Day//Year)) | 66 Individual or Joint//Group Filing ((Check Applicable Line)) _ X _ Form filed by One Reporting Person |
||||
| Tel Aviv,, L33 66994444002200 | ___ Form filed by More than One Reporting Person |
((City)) ((State)) ((Zip))
| 11Title of Security ((Instr 33)) |
22 Transaction Date ((Month //Day//Year)) |
22A Deemed Execution Date,, if any ((Month//Day //Year)) |
33 Transaction Code ((Instr 88)) |
44 Securities Acquired ((A)) or Disposed of ((D)) ((Instr 33,, 44 and 55)) |
55 Amount of Securities Beneficially Owned Following Reported Transaction((s)) ((Instr 33 and 44)) |
66 Ownership Form:: |
77 Nature of Indirect Beneficial |
|||
|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | Amount ((A)) or ((D)) | Price | Direct ((D)) or Indirect ((I)) ((Instr 44)) |
Ownership ((Instr 44)) |
|||||
| Ordinary Shares ((11)) | 0066//0066//22002255 | M | 99,,663322 | A | ((22)) | 111155,,665577 | D |
| Table II -- Derivative Securities Acquired,, Disposed of,, or Beneficially Owned |
|---|
| (( eg ,, puts,, calls,, warrants,, options,, convertible securities)) |
| 11 Title of Derivative Security ((Instr 33)) |
22 Conversion or Exercise Price of Derivative Security |
33 Transaction Date ((Month //Day//Year)) |
33A Deemed Execution Date,, if any ((Month//Day //Year)) |
44 Transaction Code ((Instr 88)) |
55 Number of Derivative Securities Acquired ((A)) or Disposed of ((D)) ((Instr 33,, 44,, and 55)) |
Date ((Month//Day//Year)) |
66 Date Exercisable and Expiration | 77 Title and Amount of Underlying Securities ((Instr 33 and 44)) |
88 Price of Derivative Security ((Instr 55)) |
99 Number of Derivative Securities Beneficially |
1100 Ownership Form of Derivative Security:: |
1111 Nature of Indirect Beneficial Ownership ((Instr 44)) |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | ((A)) | ((D)) | Date Exercisable |
Expiration Date | Title | Amount or Number of Shares |
Owned Following Reported Transaction ((s)) ((Instr 44)) |
Direct ((D)) or Indirect ((I)) ((Instr 44)) |
||||||
| Restricted Share Units |
((22)) | 0066//0066//22002255 | M | 99,,663322 | ((33)) | ((33)) | Ordinary Shares ((11)) |
99,,663322 | \$\$ 00 | 00 | D | ||||
| Restricted Share Units |
((22)) | 0066//0055//22002255 | A | 1144,,449922 | ((44)) | ((44)) | Ordinary Shares ((11)) |
1144,,449922 | \$\$ 00 | 1144,,449922 | D |
11.. The Ordinary Shares may be represented by American Depositary Shares,, each of which currently represents one Ordinary Share..
22.. Each restricted share unit represents a contingent right to receive,, at settlement,, one ordinary share or,, at the option of the Human Resources and Compensation Committee,, the cash value of one ordinary share..
//s// Dov Bergwerk as attorney--in--fact for Gerald M.. Lieberman 0066//0099//22002255
Signature of Reporting Person **** Date
Reminder:: Report on a separate line for each class of securities beneficially owned directly or indirectly..
** If the form is filed by more than one reporting person,, see Instruction 44((b))((v))..
**** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.. See 1188 U..S..C.. 11000011 and 1155 U..S..C.. 7788ff((a))..
Note:: File three copies of this Form,, one of which must be manually signed.. If space is insufficient,, see Instruction 66 for procedure..
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number..
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.